Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Comvita Limited Director's Dealing 2019

Nov 29, 2019

66182_rns_2019-11-29_999ac697-77f2-4da7-8360-8dae96b832d2.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [102 x 28] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure: Director or senior manager giving disclosure Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:

Comvita Limited 29/11/2019 30/08/2019 Robert Malcolm Major Comvita Limited n/a Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: Ordinary Nature of the affected relevant interest(s): Joint registered holder For that relevant interest- Number held in class before acquisition or disposal: 12,575 Number held in class after acquisition or disposal: 19,375 Current registered holder(s): Registered holder(s) once transfers are registered: Details of transactions giving rise to acquisition or disposal

Ordinary shares Joint registered holder Ms S A Parkinson & Mr R M Major - 12,575 Ms S A Parkinson & Mr R M Major - 19,375 Ms S A Parkinson & Mr R M Major Same as current registered holders 1

Total number of transactions to which notice relates:

Details of transactions requiring disclosure-

Details of transactions requiring disclosure-
Date oftransaction: 29/11/2019
Purchase of 6,800 ordinary shares
Nature of transaction: on market
Name ofany otherparty orparties to the transaction(if known): N/A
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by $19,720.00
converted into a cash value,describe the consideration:
Numberof financialproducts towhichthe transaction related: 1
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period: No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed duringthe closedperiod: n/a
Date of the prior written clearance (if any): n/a

Certification

I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:

==> picture [100 x 29] intentionally omitted <==

29/11/2019